Core Insights - The "Pet Economy Index" reached a historical high on September 1, with a year-to-date increase of over 44%, indicating strong performance among popular sectors [1][3] - Several companies, including Jinhe Biological, Delisi, and Yongli Co., are actively seeking to enter the pet economy sector, which is viewed as a high-potential market [1][5] Market Performance - The "Pet Economy Index" has shown significant growth, with stocks like Zhejiang Zhengte rising over 90%, and others like Yuanfei Pet, Zhongchong Co., and Shitou Co. increasing by over 60% [3] - Financial reports from pet food companies indicate solid fundamentals, with revenues for Guibao Pet, Zhongchong Co., and Lusi Co. reaching 3.221 billion, 2.432 billion, and 391 million respectively, showing year-on-year growth rates of 32.72%, 24.32%, and 11.32% [3] Fund Holdings - As of the end of June, public funds held 18.25% of Guibao Pet, making it a top holding for several funds, while Zhongchong Co.'s public fund ownership increased from 8.06% to 15.74% [4] - Yuanfei Pet's public fund ownership surged from 1.69% to 15.27% during the same period, indicating growing interest from institutional investors [4] Industry Trends - The domestic pet market is characterized by growth potential and low industry concentration, with leading brands increasing their market share [6] - Companies are focusing on product innovation and quality supply chains to meet the evolving demands of pet owners [6] Company Initiatives - Jinhe Biological announced the establishment of a wholly-owned subsidiary for pet technology, launching an intelligent pet care app that utilizes a multimodal emotional analysis model [7] - Delisi has entered into strategic partnerships for product development and market expansion in the pet food sector [7] - Yongli Co. is actively developing smart pet appliances, while Hasi Lian has expanded its business scope to include pet food sales [8]

Core Viewpoint - The "Pet Economy Index" has reached a historical high, with a year-to-date increase of over 44%, indicating strong market performance and interest from public funds in the sector [1][3]. Group 1: Market Performance - The "Pet Economy Index" has seen a significant rise, with individual stocks like Zhejiang Zhengte increasing by over 90%, and others such as Yuanfei Pet, Zhongchong Co., and Shitou Co. rising over 60% [3]. - Key companies in the pet food sector, such as Guibao Pet, Zhongchong Co., and Lusi Co., reported strong revenue growth in the first half of 2025, with revenues of 3.221 billion, 2.432 billion, and 391 million respectively, showing year-on-year increases of 32.72%, 24.32%, and 11.32% [3]. Group 2: Fund Holdings - As of the end of June, public funds held 18.25% of Guibao Pet, making it a top holding for several funds, while Zhongchong Co.'s public fund ownership increased from 8.06% at the end of last year to 15.74% [4]. - Yuanfei Pet's public fund ownership surged from 1.69% to 15.27% within the same period, indicating growing institutional interest [4]. Group 3: Industry Growth Potential - The domestic pet market is recognized for its growth potential, with a low industry concentration and a fragmented market structure, allowing leading brands to increase their market share [5]. - The pet economy is characterized by strong demand resilience, particularly in the pet food and pet medical sectors, which are highlighted as key areas for investment [2][8]. Group 4: New Developments - Companies like Jinhai Biological and Delisi are actively entering the pet sector, with Jinhai establishing a new subsidiary focused on pet technology and Delisi forming strategic partnerships for product development [6][7]. - The pet food market is projected to reach 1.585 trillion by 2024, accounting for 52.8% of the overall pet economy, while the pet medical market is expected to reach 840.6 billion, representing 28% [8].

Core Insights - The company Jinhe Biological has launched a smart pet care app called "Aichongyi," which utilizes its self-developed multimodal emotional model "Frank" to interpret pet emotions through visual and auditory inputs [1] - The app features a range of functionalities including pet emotion analysis, a pet encyclopedia, a points ecosystem, a pet community, and a pet product marketplace, with plans for future features like AI pet consultation and legal assistance [1] - Jinhe Biological is focusing on its pet business segment as a strategic priority, with a current product lineup of 15 items, including 8 health products and 1 rabies vaccine, and is in the process of applying for over ten additional products [1] Business Strategy - The overall strategy for the pet business segment is a "dual product dual line" model, which involves developing and producing competitive chemical drugs, formulations, vaccines, and health products both domestically and internationally [2] - Products developed and produced abroad can later be sold by domestic companies, creating a dual-brand strategy that includes both imported and domestically produced items [2] - The sales model is designed to operate through both online and offline channels [2]

Core Insights - The pet economy is experiencing significant growth, prompting many listed companies to enter the pet sector, reflecting a strategic intent to seek new growth avenues and the maturation of China's pet consumption market [1][7] Group 1: Company Movements - Jinhe Biological (002688.SZ) announced the establishment of a wholly-owned subsidiary, Jinhe Aichongyi (Shanghai) Biotechnology Co., with a registered capital of 10 million yuan, focusing on AI-enabled pet care solutions [1][3] - Delisi (002330.SZ) signed a strategic cooperation agreement with Xiamen Haifusheng Food Group and New Sanhe (Yantai) Food Co., to collaborate on product supply, market expansion, and the development of freeze-dried pet food [4][5] - Huashanghuan (002695.SZ) acquired a 51% stake in Fujian Lixing Food Co. for 494.7 million yuan, which has significant freeze-drying production capabilities [6] Group 2: Market Trends - The global pet industry is projected to grow from approximately $207 billion in 2024 to $270.8 billion by 2029, with a compound annual growth rate (CAGR) of 5.5% [7] - The Chinese pet market is expected to reach 300.2 billion yuan in 2024, reflecting a 7.5% increase from 2023, and is projected to grow to 404.2 billion yuan by 2027 [7] Group 3: Company Performance - Companies in the pet industry are showing strong performance, with Guibao Pet (301498.SZ) reporting a 32.72% increase in revenue to 3.221 billion yuan in the first half of 2025 [8] - Zhongchong Co. (002891.SZ) achieved a revenue of 2.432 billion yuan, a 24.32% year-on-year increase, with a net profit growth of 42.56% [8] - Tianyuan Pet (301335.SZ) reported a revenue of 1.435 billion yuan, up 14.59%, and a net profit increase of 20.14% [8] Group 4: Industry Insights - Analysts indicate that the pet sector will maintain high growth, with trends towards functional and refined products tailored to different pet life stages [9] - Companies are encouraged to innovate and differentiate to build core competitiveness amid increasing industry competition [9]

Group 1: Industry Overview - The pet economy in China is experiencing significant growth, with domestic pet consumption reaching 77.375 billion yuan in the first half of the year, a year-on-year increase of 8.84% [1] - The average revenue per pet store in mainland China was approximately 137,500 yuan in the first half of the year [1] - The pet industry is evolving from a focus on food and supplies to a comprehensive ecosystem that includes medical care, grooming, training, and insurance [1] Group 2: Market Demand and Company Performance - Zhongchong Co., Ltd. reported total revenue of 2.432 billion yuan in the first half of the year, a year-on-year increase of 24.32%, with a net profit of 203 million yuan, up 42.56% [2] - Tianyuan Pet achieved total revenue of 569 million yuan in the first quarter, a year-on-year increase of 13.07%, with a net profit of 17 million yuan, up 18.97% [2] - Yiyi Co., Ltd. reported total revenue of 485 million yuan in the first quarter, a year-on-year increase of 26.56%, with a net profit of 54 million yuan, up 27.96% [2] Group 3: Future Market Projections - The urban pet consumption market in China is expected to exceed 300 billion yuan by 2024, with the total number of dogs and cats reaching over 120 million [2] - The pet economy is projected to grow to 1.15 trillion yuan by 2028 [2] Group 4: Policy Support and Consumer Trends - Government policies are supporting the growth of the pet economy, with action plans released in Hefei and Foshan to promote high-quality development [3] - The evolving consumer mindset and increasing demand for pet health management and personalized services are driving the growth of the pet economy [3] Group 5: Technological Integration - AI technology is becoming a key driver in the pet economy, with companies integrating AI into pet services and products [4] - New AI-enabled products, such as the "AI Pet Partner" app and smart pet devices, are being developed to enhance pet care [4] Group 6: Digital Transformation in Supply Chain - Companies are focusing on digital transformation to address challenges in order management and inventory coordination [5][6] - The integration of AI and digital platforms is expected to improve operational efficiency and standardization across the pet industry [6] Group 7: Competitive Landscape - The competition in the pet economy is shifting towards technology depth and data barriers, with companies competing on algorithm accuracy and user engagement [6] - New business models may emerge, including AI-based pet health management subscription services and AI-driven customized pet products [6]

Core Insights - The article highlights the launch of "Ai Pet Easy" APP by Jinhe Biological, which is positioned as the world's first AI-driven pet care application that integrates health services and aims to revolutionize the pet economy [1][4]. Company Overview - Jinhe Biological has a strong foundation in animal health, with a comprehensive product line in pet vaccines, pharmaceuticals, and nutritional supplements, which supports the development of the "Ai Pet Easy" APP [1][2]. - The APP features an innovative emotional recognition system powered by the self-developed multimodal model Frank, which can accurately identify pets' emotional states and provide real-time feedback to owners [2][3]. Product Features - "Ai Pet Easy" APP includes multiple core functionalities such as emotional recognition, pet care encyclopedia, points system, interactive community, and personalized shopping [2][3]. - The emotional recognition system has achieved a 92% accuracy rate in identifying typical scenarios like anxiety and gastrointestinal discomfort [2]. - The APP will also offer AI pet consultations, video veterinary services, and legal assistance related to pet ownership, creating a comprehensive service ecosystem [3]. Market Potential - The pet economy is experiencing rapid growth, with the Chinese pet market expected to reach 494.3 billion yuan in 2024 and surpass 800 billion yuan by 2026 [5]. - The global pet economy is projected to exceed 3.2 trillion yuan by 2025, making it a significant area of emotional consumption [5]. - Jinhe Biological aims to leverage AI and big data to transform the pet economy from mere product transactions to a new ecosystem centered on understanding and service [6]. Industry Trends - The pet economy is becoming a new consumption blue ocean, with sectors like pet healthcare, smart hardware, insurance services, and digital content driving growth [5]. - The integration of technology in pet care is expected to unlock new functionalities, such as genetic disease prediction and public safety collaboration [5][6]. - The APP is seen as a platform-level capability that enhances communication between pets and their owners, promoting a more equitable dialogue [6][7].

Core Insights - The company Jinhe Biological is launching an AI pet companion app named "Aichongyi" in mid-August, which utilizes a multimodal emotional model called Frank to enhance communication between pet owners and their pets [1][2] - The app's initial features include emotion recognition, a pet encyclopedia, a points ecosystem, a pet community, and a pet product marketplace, aimed at accurately capturing pet emotions and providing a bridge for communication [1] - Future functionalities will expand to include AI pet consulting, video pet doctors, and legal assistance for pet-related issues, creating a comprehensive service ecosystem [1][2] Summary by Categories Product Features - "Aichongyi" app will feature emotion recognition, a pet encyclopedia, a points ecosystem, a pet community, and a pet product marketplace [1] - The app will utilize a large structured knowledge base covering pet care and scientific knowledge [1] - The marketplace will offer customized product recommendations based on pet breed and age [1] Future Development - Future features will include AI pet consulting for non-emergency situations, 24-hour video pet doctor services, and legal assistance for pet-related disputes [1] - The legal assistance will cover issues such as transportation claims, grooming and medical disputes, and rental rights for pet ownership [1] Strategic Goals - The app aims to integrate "artificial intelligence + pet industry" as a strategic engine, ultimately achieving a comprehensive service loop encompassing knowledge, products, medical services, and legal support [2] - The initiative is positioned to reshape the pet industry landscape and establish a new productive force in the pet economy [2]

Financial Performance - The company achieved a revenue of 1.39 billion CNY in the first half of the year, representing a year-on-year growth of 30.45% [1] - The net profit attributable to shareholders reached 138 million CNY, with a year-on-year increase of 51.52% [1] - The adjusted net profit was 128 million CNY, reflecting a growth of 50.88% compared to the previous year [1] Segment Performance - The pharmaceutical segment saw significant growth, generating 860 million CNY in revenue, a 72.15% increase, accounting for 61.83% of total revenue [1] - The veterinary pharmaceutical segment reported improved sales and profit levels, with major products like the antibiotic premix showing substantial growth [2] Market Dynamics - The price of raw materials, such as corn, decreased by 11.90% compared to the previous year, contributing to lower production costs [2] - The U.S. pharmaceutical market has shown consistent growth, with increased sales of key products like the water-soluble antibiotic [2] - The domestic market for the antibiotic is expected to grow due to improved profitability in the pig farming sector and expanded sales channels [2] Product Development - The company has received approval for the antibiotic in targeted animals, particularly sheep, which is expected to contribute significantly to sales growth [3] - New products, including vaccines for various diseases, are anticipated to launch within the year, enhancing the product portfolio [2][3] Strategic Initiatives - The company is focusing on expanding its pet business, with 15 products currently available and more in the pipeline [2] - A new pet app, "Ai Pet Easy," is set to launch, incorporating AI features for enhanced user engagement and potential revenue generation [2][3] Challenges and Outlook - The solid waste landfill business experienced a temporary decline in revenue, but recovery is expected in the future [4] - The overall outlook for the pharmaceutical segment remains positive, with expectations of maintaining a relatively high gross margin [3]